Centamin PLC Board Committee Changes (8698W)
24 April 2019 - 4:18PM
UK Regulatory
TIDMCEY
RNS Number : 8698W
Centamin PLC
24 April 2019
For immediate release 24 April 2019
Centamin plc ("Centamin" or "the Company")
(LSE:CEY, TSX:CEE)
Board Committee Changes
In accordance with the UKLA Listing Rule 9.6.11R (3), Centamin
is pleased to announce the following Board committee changes:
-- Dr Sally Eyre, Independent Non-Executive Director, will join
the Remuneration Committee, with immediate effect.
-- Mark Bankes, Independent Non-Executive Director, will join
the Nomination Committee and step down from the Remuneration
Committee, with immediate effect.
The Remuneration Committee now comprises of G. Edward Haslam
(Chair), Mark Arnesen and Dr Sally Eyre.
The Nomination Committee now comprises of G. Edward Haslam
(Chair), Mark Arnesen, Alison Baker and Mark Bankes.
Full Board Committee details including composition can be found
on our website:
https://www.centamin.com/investors/corporate-governance.
This announcement contains regulated information.
Enquiries
For further information, please visit the website
www.centamin.com or contact:
Centamin plc Buchanan
Andrew Pardey, Chief Executive Officer Bobby Morse
Alexandra Carse, Investor Relations Chris Judd
alexandra.carse@centamin.je centamin@buchanan.uk.com
_____________________________________________________________________________________________________
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCDGGDSRUDBGCX
(END) Dow Jones Newswires
April 24, 2019 02:01 ET (06:01 GMT)
Centamin (LSE:CEY)
Historical Stock Chart
From Apr 2024 to May 2024
Centamin (LSE:CEY)
Historical Stock Chart
From May 2023 to May 2024